Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
STRATEC Biomed N (Xetra)
Závěr k 13.2.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
19,92 1,63 0,32 293 273
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiStratec SE
TickerSBS
Kmenové akcie:Ordinary Shares
RICSBSG.DE
ISINDE000STRA555
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2025 1 420
Akcie v oběhu k 30.09.2025 12 155 942
MěnaEUR
Kontaktní informace
UliceGewerbestr. 37
MěstoBIRKENFELD
PSČ75217
ZeměGermany
Kontatní osobaJan Keppeler
Funkce kontaktní osobyHead of Investor Relations, Sustainability and Corporate Communications
Telefon49 708 279 160
Fax4970827916999
Kontatní telefon49708 279 166 515

Business Summary: Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Financial Summary: BRIEF: For the three months ended 30 September 2025, Stratec SE revenues decreased 67% to EUR57M. Net income decreased 69% to EUR1.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects Other Operating Income decrease of 71% to EUR1.1M (income), Other interest expenses decrease from EUR89K (income) to EUR117K (expense).
Odvětvová klasifikace
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYBusiness Services
MGSECTORServices
NAICSOther Scientific and Technical Consulting Services
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICSOther Specialized Design Services
NAICSSoftware Publishers
NAICSSurgical and Medical Instrument Manufacturing
NAICSIn-Vitro Diagnostic Substance Manufacturing
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSSoftware Publishers
NAICS2007Electromedical Apparatus Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Software Publishers
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Software Publishers
SICServices, Nec
SICCommercial Physical Research
SICBusiness Services, Nec
SICPrepackaged Software
SICSurgical And Medical Instruments
SICDiagnostic Substances
SICElectromedical Equipment
SICAnalytical Instruments



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the Supervisory BoardGeorg Heni6720.05.202220.05.2022
Chairman of the Management Board, Chief Executive OfficerMarcus Wolfinger5701.04.201001.07.1999
Independent Deputy Chairman of the Supervisory BoardFrank Hiller5926.11.202029.05.2019
Chief Financial Officer, Member of the Management BoardTanja Buecherl-01.11.202501.11.2025
Director - Sales, Member of the Management BoardGeorg Bauer5201.01.202301.01.2023
Member of the Management Board, Director - Product DevelopmentClaus Vielsack5715.02.201415.02.2014